Systemic therapy of skin metastatic melanoma with BRAF gene mutation
Purpose of the study. To conduct a comparative analysis of the effectiveness of the use of mono‑mode immuno‑oncological and targeted drugs in the first line of therapy in patients with metastatic melanoma of the skin (SMM) in patients with BRAF mutation.Patients and methods. To achieve this goal, a...
Saved in:
Main Authors: | Yu. S. Shakh-Paronyants, S. V. Cheporov, N. P. Shiryaev, A. V. Ukgarskiy, P. V. Nesterov, N. S. Korzina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2023-03-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/869 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
by: Jianhao Bai, et al.
Published: (2025-01-01) -
A scoping review examining the relationship between green tea and skin cancers
by: Ram Lakhan, et al.
Published: (2019-11-01) -
Melanoma genomics – will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2024-09-01) -
Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway
by: Xing Luo, et al.
Published: (2025-01-01) -
Synchronous melanomas: one on tattoo and one on healthy skin
by: Francesco Ricci, et al.
Published: (2025-02-01)